https://www.selleckchem.com/pr....oducts/ll37-human.ht
Pseudohypoaldosteronism type 1 (PHA1) may manifest in the neonatal period as a life-threatening salt-wasting syndrome providing challenges in recognition and treatment. This case describes a newborn who developed severe dehydration and electrolyte imbalances and subsequently was found to have a novel SCNN1B gene variant resulting in autosomal recessive systemic PHA1.Purpose For patient comfort and safety, irradiation times should be kept at a minimum while maintaining high treatment quality. In this study of high dose rate (HDR) ther
Beğen
Yorum Yap
Paylaş
